GSK press releases
Follow
Blujepa (gepotidacin) approved by US FDA for treatment of uncomplicated urinary tract infections (uUTIs) in female adults and paediatric patients 12 years of age and older
Blujepa is the first in a new class of oral antibiotics for uUTIs in nearly 30 years.
